Boehringer records 7.1% OTC increase in 2015

19 April 2016 - Deborah Wilkes

Archived

Boehringer Ingelheim said worldwide sales by its Consumer Health Care business increased by 7.1% on a currency-adjusted basis to EUR1.51 billion (US$1.72 billion) in 2015. The rise at the OTC business, which could soon be owned by Sanofi, was 5.3% as reported.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: